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Abstract
Background and objectives: Despite the presence of a universal healthcare system it is 
unclear if there is inter-centre variation in access to kidney transplantation in the UK. This 
study aims to assess whether equity exists in access to kidney transplantation in the UK 
after adjustment for patient specific factors and centre practice patterns.
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Design, setting, participants, and measurements: Prospective observational cohort study 
including all 71 UK kidney Centers. Incident kidney replacement therapy (KRT) patients 
recruited between November 2011-March 2013 as part of the Access to Transplantation and 
Transplant Outcome Measures study (ATTOM) were analysed to assess pre-emptive listing 
(n=2676) and listing within 2 years of starting dialysis (n=1970) by centre. 
Results: 706 participants (26%) were listed pre-emptively whilst 585 (30%) were listed 
within 2 years of commencing dialysis. The IQR across Centers was 6-33% for pre-emptive 
listing and 25-40% for listing after starting dialysis. Patient-factors including increasing age, 
most co-morbidities, BMI >35kg/m2 and lower socioeconomic status were associated with a 
lower likelihood of being listed and accounted for 89% and 97% of measured inter-centre 
variation, for pre-emptive listing and listing within 2 years of starting dialysis respectively. 
Ethnic minority associations were inconsistent and reduced access was only seen for pre-
emptive listing with Asian (OR 1.42; CI:1.12-1.79) and Black (OR 1.04; CI:0.76-1.43) 
participants associated with reduced access. As for centre factors, being registered at a 
transplanting-centre (OR 3.1; CI: 2.36-4.07) and a universal approach to discussing 
transplantation (OR 1.4; CI: 1.08-1.78) were associated with higher pre-emptive listing, 
whilst utilising a written protocol was associated negatively with listing within 2 years of 
starting dialysis (OR 0.7; CI: 0.58-0.9). 
Conclusions: Patient case-mix accounts for most of the inter-centre variation seen in 
access to transplantation in the UK with practice patterns also contributing some variation. 
Socioeconomic inequity exists despite having a universal healthcare system. 
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Introduction
In the UK, it is expected that 2.6 million adults are living with CKD stage 3-51, with over sixty-
three thousand patients receiving renal replacement therapy (RRT) for end-stage kidney 
disease (ESKD)2. Rates of RRT have risen in most high income countries in the last few 
decades (including the UK)3,4 and are greater in lower socioeconomic groups5,6 and in ethnic 
minorities5,7. Though many undergo dialysis, it is recognized that for ‘suitable patients’ with 
ESKD, kidney transplantation confers both better clinical outcomes compared to dialysis8,9, 
and leads to improvements in self-reported health10, and is therefore the preferred RRT 
modality.  
The UK National Health Service was founded on the principle of delivering equitable 
healthcare based on need and not the ability to pay and was ranked first on equity in a 
recent international healthcare comparison11. Equity is a key consideration for assessing the 
pathway to kidney transplantation for patients with ESKD. Achieving prompt assessment and 
timely activation on the transplant waiting list is crucial to accessing transplantation. 
Increasing length of time on dialysis adversely affects graft and patient survival12, and 
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deceased donor organ allocation algorithms in many countries (including the UK) give 
priority to those who have spent greater time on the waiting list.
Despite national clinical practice guidelines for transplant assessment, retrospective 
analyses of UK Renal and Transplant Registries data suggest there is variation in access to 
listing for transplantation between kidney Centers13-15; and that although ethnic minorities 
and individuals from lower socioeconomic groups have a higher incidence of ESKD5-7, they 
have reduced access to transplantation14-17. It is not known whether this difference is due to 
a higher burden of co-morbidity associated with ethnic minority status or lower 
socioeconomic status, or due to differences in centre practices that might disadvantage 
these groups14. Studies to date have been limited in their ability to examine these factors 
due to their retrospective design and use of routine and limited registry data. 
This study uses a prospective cohort of patients starting RRT recruited to the Access to 
Transplantation and Transplant Outcome Measures (ATTOM) study18 to determine (i) if 
access to pre-emptive listing (being listed before starting dialysis) and to listing within 2 
years of starting dialysis, is equitable for socially deprived and ethnic minority populations in 
the UK after morbidity adjustment; and ii) whether centre-specific factors are associated with 
access to transplant listing.
Methods
Study Population
In the UK there are 71 kidney Centers (23 transplanting and 48 non-transplanting Centers) 
which collectively provide RRT for all patients in the UK as well as managing all patients 
approaching ESKD. In each centre, over a 12-month period, between 1 November 2011 and 
31 March 2013 all incident dialysis patients and incident kidney transplant recipients aged 
18-75 years of age were recruited at the time of starting dialysis or transplantation as part of 
the ATTOM Study. ATTOM is a national prospective cohort study investigating the factors 
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that influence access, clinical and patient-reported outcomes and cost-effectiveness of 
kidney transplantation in the UK. Dedicated research nurses collected clinical and 
demographic information from the case notes and local electronic databases, and collected 
health status and well-being data from participants. The data were uploaded onto a secure 
website designed, developed and maintained by the UK Renal Registry (UKRR). A full 
description of the ATTOM study methods and protocol has been reported previously18. 
For the analysis of access to pre-emptive listing all incident dialysis participants (n=2623) 
and all incident transplant participants with a pre-emptive transplant (n=431) recruited to 
ATTOM were considered for inclusion (Figure 1).  Participants excluded were those with a 
previous transplant (n=251), those listed for multi-organ transplantation (n=4), those who 
recovered kidney function (n=25) and those that could not be linked to the UKRR/NHS Blood 
and Transplant (NHSBT) database (n=6). Lastly, participants who were suspended from the 
waiting list for > 30 days within 90 days of first activation (n=92) were also excluded to avoid 
any potential bias from Centers that may activate patients on the transplant list and then 
immediately suspend them before more permanent activation at a later date after more 
formal medical assessment of the patient’s suitability.
For analysis of access to the transplant waiting list within 2 years of starting dialysis, all 
incident dialysis participants that were not pre-emptively listed i.e. who were not listed before 
starting dialysis were considered (n=2348) using the same exclusion criteria (Figure 1). 
Data collection
Patient variables
Demographic, socioeconomic, clinical and comorbidity data were collected for each patient 
at the time of recruitment. Trained research nurses collected uniformly defined data items 
from patient interviews, case notes and local electronic patient information systems across 
the UK. Patient variables collected and analysed included, age, gender, ethnicity, BMI, co-
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morbidities and primary renal diagnosis. Several measures of socioeconomic status were 
also explored including:  education status, employment status, accommodation and car 
ownership. Civil status, number of children in household, number of adults in household and 
total numbers in household were other measures. Other demographic data collected and 
explored included place of birth, whether English was their first language, whether any 
assistance was needed with reading, the length of time a patient was known to kidney 
services pre RRT and in the case of listing after starting dialysis, their dialysis modality. Full 
details of how these variables were categorized can be found in Appendix S1.
Centre Variables
Thematic analysis of 45 semi-structured qualitative interviews with key stakeholders and 53 
patients conducted across 9 kidney Centers in the UK informed the development of an 
online survey, which was distributed to the Clinical Directors of all 71 UK kidney Centers19. 
This survey achieved a 100% response rate and was utilized to derive and quantify centre 
variables for analysis in this study. Centre variables examined were chosen by study 
investigators who examined the level of variance across centre responses for each potential 
variable and took into account the ability to readily categorize them. A full list of centre 
variables chosen for analysis can be found in Appendix S1.
Outcomes
Date of activation on the waiting list and, where applicable, the date of transplantation, were 
extracted from the UK Transplant Registry held by the Organ Donation and Transplantation 
Directorate of NHS Blood and Transplant. Date of death was retrieved from the UKRR 
database and the Scottish Renal Registry (SRR). 
Statistical methods
For access to pre-emptive listing a multi-level logistic regression model was constructed to 
analyse the association of patient variables (level 1) and centre factors (level 2). Individual 
Page 7 of 66
ScholarOne support: 888-503-1050
Clinical Journal of the American Society of NEPHROLOGY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
participants (Level 1) were nested within kidney Centers (Level 2) to allow for clustering of 
participants within Centers. Analysis of each patient-level factor was adjusted for all other 
patient-level factors and analysis of each centre factor was adjusted for those patient-level 
factors found to be associated with pre-emptive listing. The difference in -2*log-likelihood 
was used to compare model fit between nested models. The overall effect of centre in the 
analysis was considered by including kidney centre as a random effect. A significance level 
of <0.05 was taken as evidence of a significant association. 
For access to the transplant waiting list within 2 years of starting dialysis, time to listing was 
analysed using a multi-level Cox proportional hazards regression model. The time to listing 
was taken to be the time from start of dialysis to activation on the kidney transplant list. 
Participants were censored at 2 years or at patient death. Statistical significance was 
defined a priori as p<0.05. Proportional hazards assumptions were tested using Schoenfeld 
residuals. The presence of an overall kidney centre effect was considered using a frailty 
term whilst death was also considered as a competing risk using a Fine and Gray model in a 
separate competing risk analysis.
Multiple imputation was used to account for missing data in each analysis. For access to 
preemptive listing, data were missing for BMI (n=243), comorbidity (n= 30), time since first 
seen by a nephrologist (n=24) and socioeconomic variables (n=146). For access to listing 
after starting dialysis, data were missing for BMI (n=220), comorbidity (n=22) and 
socioeconomic variables (n=104). No participants were lost to follow up. Sensitivity analysis 
using complete case analysis did not change conclusions.
All data were analysed using SAS 9.4 (SAS Institute, Cary, NC, USA).
Results
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The baseline characteristics of participants analysed for pre-emptive listing and listing within 
2 years of starting dialysis are shown in Table 1. For pre-emptive listing, 
2676 participants were analysed following exclusion of 378 participants (12%), see methods. 
This study cohort had a median age of 57 years (interquartile range 45-66), of which 64% 
were male, 81% reported their ethnicity as White and diabetes was the most prevalent 
comorbidity (39%). Amongst socio-demographic factors, 54% of participants reported 
owning their own home with 69% owning their own car. 
As for listing within 2 years of starting dialysis, of 2348 eligible participants, 1970 participants 
were analysed following exclusion of 378 patients (16%), see methods. The median age of 
this cohort was 58 years (interquartile range 47-67 years), of which 65% were male, 80% 
reported their ethnicity as White and 45% had diabetes listed as a co-morbidity. Amongst 
socio-demographic factors, 49% of participants reported owning their own home whilst 16% 
of participants reported being in employment. Full details of these baseline characteristics 
are shown in Table 1.
Access to Pre-emptive Listing
Of 2676 participants, 706 participants (26%) were pre-emptively listed with a mean age of 49 
years. The IQR across Centers was 6%-33%. An unadjusted funnel plot showing centre 
variation in the percentage of participants pre-emptively listed is shown in Figure 2a. 
Associations between patient and centre variables and the likelihood of being pre-emptively 
listed were characterized using univariable (Appendix S2 & S3) and multivariable (Appendix 
S4) logistic regression; before proceeding to analyse them in a final multivariable logistic 
regression including imputed missing data (table 2).
Several patient factors were independently associated with reduced access to pre-emptive 
listing. These included: increasing age, ethnicity (both Asian and Black participants), most 
co-morbidities, having a BMI of >35, and not being seen by a nephrologist for at least 12 
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months before starting RRT. Lower socioeconomic status as indicated by housing tenure 
and car ownership status was also associated with reduced access. 
Three centre level factors were negatively associated with pre-emptive listing: being cared 
for primarily in a non-transplanting centre, having <6 Whole Time Equivalent (WTE) 
consultant nephrologists in the centre, and not adopting an approach where transplantation 
is discussed with all patients. The impact on centre variation of adjusting for these centre 
factors, along with patient factors, is shown in figure 2(b). Whilst inter-centre variation in pre-
emptive listing significantly reduced following the addition of centre as a random effect to the 
model there was still evidence of variation/unaccounted confounding (p=0.0007 1 df). Of the 
1020.9 (2679.2-1658.3) difference in -2logL between the null model and model with patient 
and centre variables, 89% (907) of the difference was observed when including the patient 
factors only (Appendix S5).  
Access to the Transplant Waiting List After Starting Dialysis
Of 1970 participants included in this analysis, 585 (30%) were listed within 2 years of 
starting dialysis with a mean age of 49 years. The IQR across Centers was 25%-40%. 
Associations between patient and centre variables and the likelihood of being listed after 
starting dialysis were characterized using univariable (Appendix S6 & S7) and multivariable 
(Appendix S8) Cox regression; before proceeding to analyse them in a final multivariable 
Cox proportional hazards regression model including imputed missing data (table 3).
Several patient factors were independently associated with reduced access to listing after 
starting dialysis. These included: increasing age, female gender, having vascular disease, 
heart failure, type II diabetes, the presence of blood borne viruses, a previous history of 
malignancy, being a current smoker, and having a BMI >35. 
As with pre-emptive listing, lower socioeconomic status was associated with reduced access 
to listing after starting dialysis. Living in rented/housing association accommodation, lack of 
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car ownership, and being long term sick/disabled or being retired from paid work, as 
compared to being in full time/part time employment, were all negatively associated with 
being listed within 2 years of starting dialysis. In contrast, having a university degree, being 
on Peritoneal Dialysis as opposed to Haemodialysis, and Asian ethnicity were all associated 
with an higher likelihood of being listed. 
Amongst centre practice patterns, having >6 consultant nephrologists in the centre (OR 1.3 
CI: 1.00-1.59) was associated positively with being listed within 2 years of starting dialysis as 
was having a multidisciplinary team (MDT) approach to listing all patients for transplantation 
(OR 1.2 CI: 0.99-1.52). An MDT approach was defined as having a multi-disciplinary team of 
physicians, surgeons and other allied health care professionals who regularly convened to 
discuss patients under consideration for transplant listing before activation.
Utilisation of a written protocol for listing patients for transplantation (OR 0.7 CI: 0.58-0.90) 
was negatively associated with being listed within 2 years of starting dialysis. Of the  
(7166.2-6566.8) 599.4 difference in -2logL between the null model and model with patient 
and centre variables, 97% (583.8) of the difference was observed when including the patient 
factors only (Appendix S9). After adjusting centre factors along with patient factors though 
much of the observed inter-centre variation from unadjusted analyses was again reduced 
there was still evidence of a difference between the Centers (p=0.041, 1df). 
Interactions and Competing Risk Analysis
When considering age as a linear factor, an interaction with type 2 diabetes was found to be 
important in the model (p=0.002, 1df). The association between increasing age and time to 
listing was stronger in participants with type 2 diabetes (data not shown). As for the 
competing risk analysis, sub-hazard ratios derived did not highlight any significant 
differences.
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Discussion
This national prospective cohort study of patients aged <75 years starting RRT in the UK 
found significant variation between kidney Centers in access to pre-emptive listing for kidney 
transplantation and listing after starting dialysis. This was largely explained by patient case-
mix factors though some centre level effects were also found to be important. There was 
evidence of socioeconomic inequity in both measures of listing, despite extensive 
comorbidity adjustment; ethnic minority associations were inconsistent and inequity was only 
seen for pre-emptive listing.
Strengths and Limitations
The main strengths of this study are its prospective cohort design, national 
representativeness and high levels of data completeness (especially for socioeconomic 
status and co-morbidity) which meant that it was not subject to the inherent weaknesses of 
retrospective studies that have affected studies exploring access to transplantation to date. 
As for limitations, this study was observational so causal relationships cannot be 
determined. There was also no adjustment for comorbidity severity, or for pre transplant 
work-up. In the case of access to pre-emptive listing, analyses could not take into account all 
those patients who had CKD 5 or who were approaching the need for dialysis and were 
being worked up for listing, as these patients were not recruited as part of ATTOM. There 
may also be residual confounding factors not accounted for, as suggested by the 
persistence of a centre effect in the final models.
Comparison with Other Studies and Implications on Health Policy
Lower socioeconomic status was independently associated with both lower pre-emptive 
transplant listing and a lower likelihood of being listed after starting dialysis, even after 
extensive adjustment for demographic factors and comorbidity. Though this observation 
could arise in part from residual confounding by comorbidity due to lack of data on disease 
severity, this inequity is consistent with multiple studies in the US and the UK which have 
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highlighted reduced access to the transplant waiting list in socially deprived patients14,20. 
Similarly, several studies around the world have also shown that socioeconomically deprived 
individuals are less likely to undergo pre-emptive transplantation21,22, though this has never 
been reported in the UK to date. As for potential explanations, studies, primarily in the US, 
have suggested that socially deprived patients may not appreciate the advantages of kidney 
transplantation and may be less likely to complete the pre-transplant work up20. Additionally, 
clinicians may consciously or subconsciously manage patients in ways that make it less 
likely for socially deprived patients to be listed for transplantation23. Another possible reason 
may be lower levels of health literacy amongst patients of lower socioeconomic status. This 
hypothesis is supported by studies from the US and UK24,25 and may represent an area for 
targeted interventions to reduce inequity caused by social deprivation. 
As for the association of ethnicity and the transplant pathway, this was seen to vary by 
measure; both Asian and Black participants being less likely to be pre-emptively listed as 
compared to white participants; but Asian ethnicity was associated with an higher likelihood 
of being listed after starting dialysis. Other studies have also found conflicting associations in 
terms of ethnicity. Many studies in the US16,17,20,23 and UK14,15  have reported that ethnic 
minorities have decreased access to the transplant waiting list, whilst other studies have 
reported equal access26. One explanation for differing historical outcomes may be that 
previous studies reporting that ethnic minorities having reduced access to listing may have 
been confounded, by combining and analysing pre-emptive listing and listing after starting 
dialysis together; whilst in the present study they were treated independently. It is also 
possible that the lower likelihood of pre-emptive listing in ethnic minorities is partly a 
reflection of their lower rates of live donor transplantation, found in both the US and in the 
UK27. Institutional prejudice, distrust and reluctance to engage with the medical system, 
cultural and religious beliefs, and lack of suitable donors or concern over a higher risk for 
living donors from minority ethnic backgrounds have all been cited as possible reasons for 
these disparities28-31.  Further research is clearly needed to understand potential reasons. 
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In contrast the reasons for the observation that Asian participants had an higher likelihood of 
being listed once starting dialysis are unclear. Likewise, the reasons for the observation that 
female gender was negatively associated with listing after starting dialysis but not pre-
emptive listing is uncertain; it is revealed by analyzing these cohorts separately rather than 
combining them as in studies to date, and may be due to chance. 
Whilst patient case-mix was seen to account for the majority of inter-centre variation, some 
centre practice patterns were also seen to be associated with being listed. Being registered 
at a transplanting centre was associated with an increase in pre-emptive listing but not post-
dialysis listing.  This has been described in previous retrospective studies24-25, and may 
reflect more efficient listing processes in transplanting Centers as a consequence of having 
access to on-site specialist clinicians to assist in assessing suitability; and to on-site live 
donor co-ordinators to aid earlier identification of potential living donors. 
The observation that a critical mass of consultant nephrologist availability (> 6 consultant 
nephrologists) was independently associated with a higher likelihood of listing also suggests 
a direct link between improved quality of patient care (i.e. early wait-listing) and senior 
workforce capacity. Whilst we are not able to clarify why this may be the case, a possible 
explanation is the ability to embed sub-specialist interest in transplantation and/or CKD 
pathway progress which may be more likely in larger units.  
The finding that discussing transplantation with all patients and not utilising a written protocol 
both improve listing is intriguing and has not been reported before. An inclusive approach to 
discussion about transplantation is likely to help eliminate personal bias and assist in a more 
patient-centred approach that may result in more open conversation, as well as aid in the 
early identification of potential live donors. Likewise, clinicians at Centers not using a written 
protocol (i.e. Centers which do not list patients using defined criteria as part of a in house 
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centre protocol), might benefit from listing more patients due to the ability to exercise more 
flexibility and their own personal clinical judgment which would otherwise be hampered by 
restrictions imposed by local guidelines.
Conclusions
This study has shown that patient case-mix and, to a lesser extent, centre practice patterns 
account for the majority of observed inter-centre variation in access to pre-emptive listing 
and listing after starting dialysis in the UK. However, socioeconomic inequity exists in access 
to kidney transplantation in the UK despite the existence of a universal healthcare system. 
Further research is needed to understand the causal pathways between socioeconomic 
status and listing for transplantation including the role of health literacy in influencing access 
to transplantation to reduce inequity.
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Table 1: Baseline characteristics of participants in the Access to Transplantation and 
Transplant Outcome Measures study, United Kingdom, analysed for access to pre-emptive 
kidney transplant listing and kidney transplant listing within two years of starting dialysis 
Access to Pre-emptive Listing  Access to Listing within 2 years of Starting Dialysis
Variable
Total N (%)
Number Pre-
emptively listed 
N (%)
 Total N (%)
Number Listed 
within 2 years of 
starting Dialysis N, 
(%)
Age (Mean, (SD)) 55 (13.6) 49 (12.9) 57 (13) 49 (14)
Gender
Male 1706 (64) 421 (60) 1285 (65) 406 (69)
Female 970 (36) 285 (40) 685 (35) 179 (31)
Ethnic Group
White 2177 (81) 611 (87) 1566 (80) 416 (71)
Asian 293 (11) 60 (8) 233 (12) 103 (18)
Black 177 (7) 31 (4) 146 (7) 54 (9)
Other 29 (1) 4 (1) 25 (1) 12 (2)
Primary Renal Disease
Diabetes 711 (28) 112 (16) 599 (30) 119 (20)
Glomerulonephritis 428 (16) 148 (21) 280 (14) 142 (24)
Hypertension 171 (6) 40 (6) 131 (7) 50 (9)
Missing 30 (1) 10 (1) 20 (1) 14 (2)
Other 388 (15) 88 (13) 300 (15) 75 (13)
Polycystic 249 (9) 135 (19) 114 (6) 56 (10)
Pyelonephritis 221 (8) 91 (13) 130 (7) 31 (5)
Renal vascular disease 95 (4) 12 (2) 83 (4) 9 (2)
Uncertain 383 (14) 70 (10) 313 (16) 89 (15)
BMI
Less than 20 165 (6) 40 (6) 125 (6) 41 (7)
20 - <25 729 (27) 232 (33) 497 (25) 195 (33)
25 - <30 771 (29) 274 (39) 497 (25) 186 (32)
30 - <35 435 (16) 107 (15) 328 (17) 91 (16)
35 - <40 202 (8) 24 (3) 178 (9) 34 (6)
  131 (5) 6 (1) 125 (6) 8 (1)
Missing 243 (9) 23 (3) 220 (11) 30 (5)
Diabetes
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No 1614 (60) 552 (78) 1065 (54) 398 (68)
Type 1 256 (10) 80 (11) 176 (9) 60 (10)
Type 2 776 (29) 67 (10) 709 (36) 115 (20)
Missing 27 (1.0) 7 (1) 20 (1) 12 (2)
Heart Disease
No 2159 (81) 650 (92) 1509 (77) 508 (87)
Yes 488 (18) 48 (7) 440 (22) 63 (11)
Missing 29 (1) 8 (1) 21 (1) 14 (2)
Heart Failure
No 2467 (92) 691 (98) 1776 (90) 551 (94)
Yes 178 (7) 7 (1) 171 (9) 18 (3)
Missing 31 (1) 8 (1) 23 (1) 16 (3)
Atrial Fibrillation
No 2547 (95) 687 (97) 1860 (94) 559 (96)
Yes 97 (4) 11 (2) 86 (4) 10 (2)
Missing 32 (1) 8 (1) 24 (1) 16 (3)
Cardiac Valve 
Replacement
No 2612 (98) 689 (98) 1923 (98) 568 (97)
Yes 31 (1) 7 (1) 24 (1) 1 (0.2)
Missing 33 (1) 10 (1) 23 (1) 17 (3)
Pacemaker
No 2604 (97) 694 (98) 1910 (97) 567 (97)
Yes 41 (2) 4 (0.6) 37 (2) 2 (0.3)
Missing 31 (1) 8 (1) 23 (1) 16 (3)
Cerebrovascular 
Disease
No 2422 (91) 674 (96) 1748 (89) 541 (93)
Yes 222 (8) 23 (3) 199 (10) 28 (5)
Missing 32 (1) 9 (1) 23 (1) 16 (3)
Vascular Disease
No 2432 (91) 686 (97) 1746 (89) 545 (93)
Yes 212 (8) 12 (2) 200 (10) 24 (4)
Missing 32 (1) 8 (1) 24 (1) 16 (4)
Abdominal Aortic 
Aneurysm
No 2597 (97) 693 (98) 1904 (97) 569 (97)
Yes 46 (2) 4 (0.6) 42 (2) 1 (0.2)
Missing 33 (1) 9 (1) 24 (1) 15 (3)
Respiratory Disease
No 2335 (87) 643 (91) 1692 (86) 523 (89)
Yes 310 (12) 55 (8) 255 (13) 47 (8)
Missing 31 (1) 8 (1) 23 (1) 15 (3)
Liver Disease
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No 2582 (97) 691 (98) 1891 (96) 563 (96)
Yes 64 (2) 7 (1) 57 (3) 7 (1)
Missing 30 (1) 8 (1) 22 (1) 15 (3)
Blood Borne Viruses
No 2576 (96) 688 (98) 1888 (96) 562 (96)
Yes 70 (3) 10 (1) 60 (3) 9 (2)
Missing 30 (1) 8 (1) 22 (1) 14 (2)
Malignancy
No 2328 (87) 659 93) 1669 (85) 545 (93)
Yes 321 (12) 39 (6) 282 (14) 25 (4)
Missing 27 (1) 8 (1) 19 (1) 14 (2)
Mental Illness
No 2422 (91) 657 (93) 1765 (90) 532 (91)
Yes 225 (8) 41 (6) 184 (9) 39 (7)
Missing 29 (1) 8 (1) 21 (1) 14 (2)
Dementia
No 2637 (99) 697 (99) 1940 (99) 568 (97)
Yes 8 (0.3) 1 (0.1) 7 (0.4) 1 (0.2)
Missing 31 (1) 8 (1) 23 (1) 16 (3)
Smoking
No 1145 (43) 364 (52) 781 (40) 253 (43)
Current 381 (14) 66 (9) 315 (16) 73 (13)
Ex-smoker 763 (29) 185 (26) 578 (29) 158 (27)
Don’t Know 370 (14) 85 (12) 285 (15) 93 (16)
Missing 17 (0.6) 6 (1) 11 (0.6) 8 (1)
Born in UK
No 485 (18) 86 (12) 399 (20) 149 (26)
Yes 2032 (76) 578 (82) 1454 (74) 404 (69)
Missing 159 (6) 42 (6) 117 (6) 32 (6)
English First Language
No 325 (12) 58 (8) 267 (14) 110 (19)
Yes 2192 (82) 606 (86) 1586 (81) 443 (76)
Missing 159 (6) 42 (6) 117 (6) 32 (6)
Read Help 
No 2058 (77) 597 (85) 1461 (74) 459 (78)
Yes 457 (17) 66 (9) 391 (20) 94 (16)
Missing 161 (6) 43 (6) 118 (6) 32 (6)
Accommodation
Owned by you (outright 
or with a mortgage) 1436 (54) 468 (66) 968 (49) 281 (48)
Part rent, part owned 
(shared ownership) 55 (2) 11 (2) 44 (2) 17 (3)
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Rented privately from 
Council/ Housing 
Association
861 (32) 145 (21) 716 (36) 203 (35)
Other 154 (6) 37 (5) 117 (6) 49 (8)
Missing 170 (6) 45 (6) 125 (6) 35 (6)
Employment
Working PT/FT 627 (23) 316 (45) 311 (16) 185 (32)
Long term sick/disabled 700 (26) 132 (19) 568 (29) 156 (27)
Retired from paid work 889 (33) 124 (18) 765 (39) 114 (20)
Unemployed 173 (7) 37 (5) 136 (7) 65 (11)
Other 122 (5) 52 (7) 70 (4) 33 (6)
Missing 165 (6) 45 (6) 120 (6) 32 (6)
Education
Degree, Higher or NVQ 
4-5 446 (17) 160 (23) 286 (15) 137 (23)
GCSE, A-level or NVQ 1-
3 1051 (39) 346 (49) 705 (36) 241 (41)
No Qualifications 1023 (38) 160 (23) 863 (44) 175 (30)
Missing 156 (6) 40 (6) 116 (6) 32 (6)
Car Ownership
No 658 (25) 76 (11) 582 (30) 153 (26)
Yes 1852 (69) 586 (83) 1266 (64) 399 (68)
Missing 166 (6) 44 (6) 122 (6) 33 (6)
Civil Status
Single (never married) 480 (18) 136 (19) 344 (17) 136 (23)
Married 1386 (52) 388 (55) 998 (50) 286 (49)
Living with partner 173 (7) 64 (9) 109 (6) 43 (8)
Divorced 238 (9) 49 (7) 189 (10) 49 (8)
Separated (but still 
legally married) 81 (3) 12 (2) 69 (4) 19 (3)
Widowed 148 (6) 14 (2) 134 (7) 17 (3)
Missing 170 (6) 43 (6) 127 (6) 35 (6)
Children in Household
None 1978 (74) 472 (67) 1506 (76) 387 (66)
1 264 (10) 97 (14) 167 (9) 76 (13)
2 or more 265 (10) 92 (13) 173 (9) 88 (15)
Missing 169 (6) 45 (6) 124 (6) 34 (6)
Adults in Household
0-1 699 (26) 127 (18) 572 (29) 154 (26)
2 1261 (47) 378 (54) 883 (45) 263 (45)
3 or more 545 (20) 156 (22) 389 (20) 134 (23)
Missing 171 (6) 45 (6)  126 (6) 34 (6)
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Table 2 – Associations of patient-level and centre-level characteristics with listing for pre-
emptive kidney transplantation*.
Variable N
Adjusted Odds Ratio 
(95% Confidence 
Interval)
p-value
Patient Variables±
Age <0.0001
18-29 149 1
30-39 235 0.9 (0.51-1.57)
40-49 455 0.79 (0.47-1.32)
50-59 657 0.57 (0.34-0.97)
60-64 372 0.47 (0.26-0.87)
65-75 808 0.19 (0.1-0.37)
Ethnic Group <0.0001
White 2177 1
Asian 293 0.49 (0.33-0.72)
Black 177 0.43 (0.26-0.71)
Other 29 0.23 (0.07-0.8)
BMI <0.0001
Less than 20 184 0.66 (0.4-1.09)
20 - <25 798 1
25 - <30 845 1.31 (0.99-1.73)
30 - <35 482 0.97 (0.69-1.38)
35 - <40 223 0.31 (0.18-0.54)
  144 0.12 (0.05-0.28)
Time Since First Seen 
by Nephrologist <0.0001
<1 Year 701 1
1-3 Years 619 8.12 (5.44-12.1)
>3 Years 1355 11.55 (8.05-16.55)
Diabetes <0.0001
No 1626 1
Type 1 266 1.12 (0.76-1.64)
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Type 2 784 0.37 (0.26-0.52)
Peripheral Vascular 
Disease  
No 2456 1
Yes 220 0.29 (0.13-0.61) 0.0013
Heart Disease 
No 2170 1
Yes 506 0.55 (0.36-0.82) 0.004
Heart Failure 
No 2490 1
Yes 186 0.25 (0.08-0.77) 0.016
Cerebrovascular 
Disease 
No 2448 1
Yes 228 0.53 (0.3-0.92) 0.025
Malignancy 
No 2340 1
Yes 336 0.33 (0.2-0.53) <0.0001
Smoking 0.0005
No 1148 1
Current 383 0.53 (0.36-0.78)
Ex-smoker 769 0.95 (0.72-1.25)
Don’t know 377 0.75 (0.52-1.07)
Socioeconomic 
Variables
Employment <0.0001
Working full time/ part 
time 667 1
Long term sick/disabled 746 0.42 (0.3-0.58)
Retired from paid work 948 0.55 (0.37-0.82)
Unemployed 185 0.51 (0.31-0.85)
Other 130 0.93 (0.54-1.6)
Accommodation <0.0001
Owned by you (Outright 
or with a Mortgage) 1533 1
Other 166 0.58 (0.34-1.0)
Part rent, Part owned 
(shared ownership) 59 0.32 (0.13-0.74)
Rented Privately from 
Council / Housing 
Association 
918 0.55 (0.41-0.75)
Car ownership
No 701 1
Yes 1975 1.98 (1.41-2.76) <0.0001
Education  0.08
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GCSE, A-level or NVQ 
1-3 1115 1.26 (0.96-1.67)
Degree, Higher or NVQ 
4-5 477 1.06 (0.74-1.51)
No Qualifications 1084 1
Centre Level 
Variables 
Transplanting Centre
No 48 1
Yes 23 3.1 (2.36-4.07) <0.0001
No. of Consultant 
Nephrologists
 30 1
>6 41 2.16 (1.5-3.1) <0.0001
Transplantation 
Discussed with All 
Patients
No 20 1
Yes 51 1.39 (1.08-1.78) 0.0094
* Derived using multivariable logistic regression and multiple imputation. 20 imputed data 
sets were modelled separately then combined to produce final parameter estimates.
± Missing data was imputed for BMI (n=243), comorbidity (n= 30), time since first seen by a 
nephrologist (n=24) and socioeconomic variables (n=146).
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Table 3 – Associations of patient-level and centre-level characteristics with listing for kidney 
transplantation within 2 years of starting dialysis*
Variable N
Adjusted Hazard 
Ratio (95% 
Confidence Interval)
p-value
Patient Variables
Age <0.0001
18-29 86 1
30-39 137 0.8 (0.56-1.12)
40-49 280 0.64 (0.46-0.89)
50-59 462 0.35 (0.25-0.49)
60-64 290 0.27 (0.18-0.41)
65-75 715 0.15 (0.1-0.23)
Gender
Male 1285 1
Female 685 0.82 (0.68-0.99) 0.035
Ethnic Group 0.002
White 1566 1
Asian 233 1.42 (1.12-1.79)
Black 146 1.04 (0.76-1.43)
Other 25 1.56 (0.85-2.87)
BMI <0.0001
Less than 20 143 0.85 (0.6-1.21)
20 - <25 561 1
25 - <30 558 1.15 (0.93-1.42)
30 - <35 369 0.88 (0.67-1.14)
35 - <40 200 0.48 (0.33-0.7)
  141 0.15 (0.08-0.3)
Dialysis Modality
Haemodialysis 1603 1
Peritoneal dialysis 367 1.34 (1.1-1.64) 0.004
Diabetes <0.0001
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No 1085 1
Type 1 176 0.76 (0.57-1.02)
Type 2 709 0.62 (0.49-0.79)
Peripheral Vascular 
Disease 
No 1764 1
Yes 206 0.6 (0.37-0.96) 0.035
Heart Disease 
No 1520 1
Yes 451 0.8 (0.59-1.09) 0.16
Heart Failure 
No 1797 1
Yes 173 0.58 (0.36-0.93) 0.025
Blood Borne Viruses
No 1906 1
Yes 64 0.36 (0.18-0.71) 0.0035
Malignancy 
No 1677 1
Yes 293 0.33 (0.2-0.53) <0.0001
Smoking 0.05
No 784 1
Current 316 0.76 (0.58-1.0)
Ex-smoker 582 1.17 (0.95-1.45)
Don’t know 289 1.06 (0.82-1.36)
Socioeconomic 
Variables
Employment <0.0001
Working full time/ part 
time 331 1
Long term sick/disabled 606 0.54 (0.43-0.68)
Retired from paid work 814 0.58 (0.42-0.8)
Unemployed 144 0.77 (0.56-1.06)
Other 75 0.74 (0.5-1.1)
Accommodation 0.009
Owned by you (Outright 
or with a Mortgage) 1035 1
Other 126 0.81 (0.58-1.13)
Part rent, Part owned 
(shared ownership) 47 1.07 (0.64-1.8)
Rented Privately from 
Council / Housing 
Association 
762 0.76 (0.61-0.94)
Car ownership
No 619 0.73 (0.6-0.9) 0.0026
Yes 1351 1
Education 0.01
Page 28 of 66
ScholarOne support: 888-503-1050
Clinical Journal of the American Society of NEPHROLOGY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
GCSE, A-level or NVQ 
1-3 749 1.05 (0.85-1.3)
Degree, Higher or NVQ 
4-5 305 1.38 (1.07-1.79)
No Qualifications 916 1
Centre Level Variables 
Consultant 
Nephrologists
 30 1
>6 41 1.26 (1.0-1.59) 0.054
MDT
No 17 1
Yes 54 1.23 (0.99-1.52) 0.057
Written Protocol for 
listing
No 21 1
Yes 50 0.72 (0.58-0.9) 0.0033
* Derived using multivariable Cox regression and multiple imputation. 20 imputed data sets 
were modelled separately then combined to produce final parameter estimates.
± Missing data was imputed for BMI (n=220), comorbidity (n=22) and socioeconomic 
variables (n=104).
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Figure Legend 
Figure 1(a). Flow diagram showing the study recruitment of participants (with inclusion and 
exclusion criteria) for (1) access to pre-emptive listing and (2) listing after starting dialysis
Figure 1 (b). Flow diagram showing the study recruitment of participants (with inclusion and 
exclusion criteria) for (1) access to pre-emptive listing and (2) listing after starting dialysis
Figure 2 (a). Unadjusted funnel plot showing variation in proportion listed for pre-emptive 
kidney transplant by centre according to number of participants evaluated.
*Centers with less than 10 observations are not shown
** Number of Patients, denotes the number of participants from a given centre that were 
analysed (from cohort of patients recruited at each centre for the ATTOM study)
Figure 2(b). Risk adjusted funnel plot showing variation in proportion listed for pre-emptive 
kidney transplant by centre according to number of participants evaluated 
*Risk adjusted for all patient and centre factors, using the mean of each adjustment variable 
across the cohort, associated with pre-emptive listing as highlighted in table 2. Centers with 
less than 10 observations are not shown.
** Number of Patients, denotes the number of participants from a given centre that were 
analysed (from cohort of patients recruited at each centre for the ATTOM study)
Page 30 of 66
ScholarOne support: 888-503-1050
Clinical Journal of the American Society of NEPHROLOGY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Figure 1(a)
Figure 2(b)
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Figure 2 (a)
Figure 2(b)
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Methods and Cohort Results
Is there inequity in access to kidney 
transplantation in the United Kingdom?
Rishi Pruthi, Matthew Robb, Gabriel Oniscu, Charles Tomson, et al. Inequity in 
Access to Transplantation in the UK: A Prospective Observational Cohort 
Study. CJASN doi: 10.2215/CJN.11460919. Visual Abstract by Beatrice 
Concepcion, MD.
Conclusion Patient case-mix accounts for most of the inter-center 
variation seen in access to transplantation in the UK. Socioeconomic 
inequity exists despite having a universal healthcare system.
Prospective 
observational 
cohort study
72 UK kidney 
centers
Incident KRT 
patients in
ATTOM study 
of 2676 incident 
KRT patients
Preemptive listing
Listing within 2 years of 
initiating dialysis
Nov 2011-
March 2013
26%
of 1970 patients 
starting dialysis
30%
Lower likelihood Higher likelihood
Patient 
factors
Center
factors
Patient 
factors
Center
factors
Lower likelihood Higher likelihood
• Older age
• Non-white
• Most co-morbidities
• BMI >35
• Working full time
• Car ownership
• Transplanting center
• Transplantation discussed 
with all patients
• Older age
• Most co-morbidities
• BMI >35
• Peritoneal dialysis
• Working full time
• Car ownership
• Written protocol for 
listing
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Abstract 
Background and objectives: Despite the presence of a universal healthcare system it is 
unclear if there is inter-centre variation in access to kidney transplantation in the UK. This 
study aims to assess whether equity exists in access to kidney transplantation in the UK 
after adjustment for patient specific factors and centre practice patterns. 
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Design, setting, participants, and measurements: Prospective observational cohort study 
including all 71 UK kidney centres. Incident kidney replacement therapy (KRT) patients 
recruited between November 2011-March 2013 as part of the Access to Transplantation and 
Transplant Outcome Measures study (ATTOM) were analysed to assess pre-emptive listing 
(n=2676) and listing within 2 years of starting dialysis (n=1970) by centre.  
Results: 706 participants (26%) were listed pre-emptively whilst 585 (30%) were listed 
within 2 years of commencing dialysis. The IQR across centres was 6-33% for pre-emptive 
listing and 25-40% for listing after starting dialysis. Patient-factors including increasing age, 
most co-morbidities, BMI >35kg/m2 and lower socioeconomic status were associated with a 
lower likelihood of being listed and accounted for 89% and 97% of measured inter-centre 
variation, for pre-emptive listing and listing within 2 years of starting dialysis respectively. 
Ethnic minority associations were inconsistent and reduced access was only seen for pre-
emptive listing with Asian (OR 1.42; CI:1.12-1.79) and Black (OR 1.04; CI:0.76-1.43) 
participants associated with reduced access. As for centre factors, being registered at a 
transplanting-centre (OR 3.1; CI: 2.36-4.07) and a universal approach to discussing 
transplantation (OR 1.4; CI: 1.08-1.78) were associated with higher pre-emptive listing, 
whilst utilising a written protocol was associated negatively with listing within 2 years of 
starting dialysis (OR 0.7; CI: 0.58-0.9).  
Conclusions: Patient case-mix accounts for most of the inter-centre variation seen in 
access to transplantation in the UK with practice patterns also contributing some variation. 
Socioeconomic inequity exists despite having a universal healthcare system.  
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Introduction 
In the UK, it is expected that 2.6 million adults are living with CKD stage 3-51, with over sixty-
three thousand patients receiving renal replacement therapy (RRT) for end-stage kidney 
disease (ESKD)2. Rates of RRT have risen in most high income countries in the last few 
decades (including the UK)3,4 and are greater in lower socioeconomic groups5,6 and in ethnic 
minorities5,7. Though many undergo dialysis, it is recognized that for ‘suitable patients’ with 
ESKD, kidney transplantation confers both better clinical outcomes compared to dialysis8,9, 
and leads to improvements in self-reported health10, and is therefore the preferred RRT 
modality.   
 
The UK National Health Service was founded on the principle of delivering equitable 
healthcare based on need and not the ability to pay and was ranked first on equity in a 
recent international healthcare comparison11. Equity is a key consideration for assessing the 
pathway to kidney transplantation for patients with ESKD. Achieving prompt assessment and 
timely activation on the transplant waiting list is crucial to accessing transplantation. 
Increasing length of time on dialysis adversely affects graft and patient survival12, and 
Page 37 of 66
ScholarOne support: 888-503-1050
Clinical Journal of the American Society of NEPHROLOGY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
deceased donor organ allocation algorithms in many countries (including the UK) give 
priority to those who have spent greater time on the waiting list. 
 
Despite national clinical practice guidelines for transplant assessment, retrospective 
analyses of UK Renal and Transplant Registries data suggest there is variation in access to 
listing for transplantation between kidney centres13-15; and that although ethnic minorities and 
individuals from lower socioeconomic groups have a higher incidence of ESKD5-7, they have 
reduced access to transplantation14-17. It is not known whether this difference is due to a 
higher burden of co-morbidity associated with ethnic minority status or lower socioeconomic 
status, or due to differences in centre practices that might disadvantage these groups14. 
Studies to date have been limited in their ability to examine these factors due to their 
retrospective design and use of routine and limited registry data.  
 
This study uses a prospective cohort of patients starting RRT recruited to the Access to 
Transplantation and Transplant Outcome Measures (ATTOM) study18 to determine (i) if 
access to pre-emptive listing (being listed before starting dialysis) and to listing within 2 
years of starting dialysis, is equitable for socially deprived and ethnic minority populations in 
the UK after morbidity adjustment; and ii) whether centre-specific factors are associated with 
access to transplant listing. 
 
Methods 
Study Population 
In the UK there are 71 kidney centres (23 transplanting and 48 non-transplanting centres) 
which collectively provide RRT for all patients in the UK as well as managing all patients 
approaching ESKD. In each centre, over a 12-month period, between 1 November 2011 and 
31 March 2013 all incident dialysis patients and incident kidney transplant recipients aged 
18-75 years of age were recruited at the time of starting dialysis or transplantation as part of 
the ATTOM Study. ATTOM is a national prospective cohort study investigating the factors 
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that influence access, clinical and patient-reported outcomes and cost-effectiveness of 
kidney transplantation in the UK. Dedicated research nurses collected clinical and 
demographic information from the case notes and local electronic databases, and collected 
health status and well-being data from participants. The data were uploaded onto a secure 
website designed, developed and maintained by the UK Renal Registry (UKRR). A full 
description of the ATTOM study methods and protocol has been reported previously18.  
 
For the analysis of access to pre-emptive listing all incident dialysis participants (n=2623) 
and all incident transplant participants with a pre-emptive transplant (n=431) recruited to 
ATTOM were considered for inclusion (Figure 1).  Participants excluded were those with a 
previous transplant (n=251), those listed for multi-organ transplantation (n=4), those who 
recovered kidney function (n=25) and those that could not be linked to the UKRR/NHS Blood 
and Transplant (NHSBT) database (n=6). Lastly, participants who were suspended from the 
waiting list for > 30 days within 90 days of first activation (n=92) were also excluded to avoid 
any potential bias from centres that may activate patients on the transplant list and then 
immediately suspend them before more permanent activation at a later date after more 
formal medical assessment of the patient’s suitability. 
 
For analysis of access to the transplant waiting list within 2 years of starting dialysis, all 
incident dialysis participants that were not pre-emptively listed i.e. who were not listed before 
starting dialysis were considered (n=2348) using the same exclusion criteria (Figure 1).  
 
Data collection 
Patient variables 
Demographic, socioeconomic, clinical and comorbidity data were collected for each patient 
at the time of recruitment. Trained research nurses collected uniformly defined data items 
from patient interviews, case notes and local electronic patient information systems across 
the UK. Patient variables collected and analysed included, age, gender, ethnicity, BMI, co-
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morbidities and primary renal diagnosis. Several measures of socioeconomic status were 
also explored including:  education status, employment status, accommodation and car 
ownership. Civil status, number of children in household, number of adults in household and 
total numbers in household were other measures. Other demographic data collected and 
explored included place of birth, whether English was their first language, whether any 
assistance was needed with reading, the length of time a patient was known to kidney 
services pre RRT and in the case of listing after starting dialysis, their dialysis modality. Full 
details of how these variables were categorized can be found in Appendix S1. 
 
Centre Variables 
Thematic analysis of 45 semi-structured qualitative interviews with key stakeholders and 53 
patients conducted across 9 kidney centres in the UK informed the development of an online 
survey, which was distributed to the Clinical Directors of all 71 UK kidney centres19. This 
survey achieved a 100% response rate and was utilized to derive and quantify centre 
variables for analysis in this study. Centre variables examined were chosen by study 
investigators who examined the level of variance across centre responses for each potential 
variable and took into account the ability to readily categorize them. A full list of centre 
variables chosen for analysis can be found in Appendix S1. 
 
Outcomes 
Date of activation on the waiting list and, where applicable, the date of transplantation, were 
extracted from the UK Transplant Registry held by the Organ Donation and Transplantation 
Directorate of NHS Blood and Transplant. Date of death was retrieved from the UKRR 
database and the Scottish Renal Registry (SRR).  
 
Statistical methods 
For access to pre-emptive listing a multi-level logistic regression model was constructed to 
analyse the association of patient variables (level 1) and centre factors (level 2). Individual 
Page 40 of 66
ScholarOne support: 888-503-1050
Clinical Journal of the American Society of NEPHROLOGY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
participants (Level 1) were nested within kidney centres (Level 2) to allow for clustering of 
participants within centres. Analysis of each patient-level factor was adjusted for all other 
patient-level factors and analysis of each centre factor was adjusted for those patient-level 
factors found to be associated with pre-emptive listing. The difference in -2*log-likelihood 
was used to compare model fit between nested models. The overall effect of centre in the 
analysis was considered by including kidney centre as a random effect. A significance level 
of <0.05 was taken as evidence of a significant association.  
 
For access to the transplant waiting list within 2 years of starting dialysis, time to listing was 
analysed using a multi-level Cox proportional hazards regression model. The time to listing 
was taken to be the time from start of dialysis to activation on the kidney transplant list. 
Participants were censored at 2 years or at patient death. Statistical significance was 
defined a priori as p<0.05. Proportional hazards assumptions were tested using Schoenfeld 
residuals. The presence of an overall kidney centre effect was considered using a frailty 
term whilst death was also considered as a competing risk using a Fine and Gray model in a 
separate competing risk analysis. 
 
Multiple imputation was used to account for missing data in each analysis. For access to 
preemptive listing, data were missing for BMI (n=243), comorbidity (n= 30), time since first 
seen by a nephrologist (n=24) and socioeconomic variables (n=146). For access to listing 
after starting dialysis, data were missing for BMI (n=220), comorbidity (n=22) and 
socioeconomic variables (n=104). No participants were lost to follow up. Sensitivity analysis 
using complete case analysis did not change conclusions. 
 
All data were analysed using SAS 9.4 (SAS Institute, Cary, NC, USA). 
 
Results 
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The baseline characteristics of participants analysed for pre-emptive listing and listing within 
2 years of starting dialysis are shown in Table 1. For pre-emptive listing,  
2676 participants were analysed following exclusion of 378 participants (12%), see methods. 
This study cohort had a median age of 57 years (interquartile range 45-66), of which 64% 
were male, 81% reported their ethnicity as White and diabetes was the most prevalent 
comorbidity (39%). Amongst socio-demographic factors, 54% of participants reported 
owning their own home with 69% owning their own car.  
 
As for listing within 2 years of starting dialysis, of 2348 eligible participants, 1970 participants 
were analysed following exclusion of 378 patients (16%), see methods. The median age of 
this cohort was 58 years (interquartile range 47-67 years), of which 65% were male, 80% 
reported their ethnicity as White and 45% had diabetes listed as a co-morbidity. Amongst 
socio-demographic factors, 49% of participants reported owning their own home whilst 16% 
of participants reported being in employment. Full details of these baseline characteristics 
are shown in Table 1. 
 
Access to Pre-emptive Listing 
Of 2676 participants, 706 participants (26%) were pre-emptively listed with a mean age of 49 
years. The IQR across centres was 6%-33%. An unadjusted funnel plot showing centre 
variation in the percentage of participants pre-emptively listed is shown in Figure 2a. 
Associations between patient and centre variables and the likelihood of being pre-emptively 
listed were characterized using univariable (Appendix S2 & S3) and multivariable (Appendix 
S4) logistic regression; before proceeding to analyse them in a final multivariable logistic 
regression including imputed missing data (table 2). 
 
Several patient factors were independently associated with reduced access to pre-emptive 
listing. These included: increasing age, ethnicity (both Asian and Black participants), most 
co-morbidities, having a BMI of >35, and not being seen by a nephrologist for at least 12 
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months before starting RRT. Lower socioeconomic status as indicated by housing tenure 
and car ownership status was also associated with reduced access.  
Three centre level factors were negatively associated with pre-emptive listing: being cared 
for primarily in a non-transplanting centre, having <6 Whole Time Equivalent (WTE) 
consultant nephrologists in the centre, and not adopting an approach where transplantation 
is discussed with all patients. The impact on centre variation of adjusting for these centre 
factors, along with patient factors, is shown in figure 2(b). Whilst inter-centre variation in pre-
emptive listing significantly reduced following the addition of centre as a random effect to the 
model there was still evidence of variation/unaccounted confounding (p=0.0007 1 df). Of the 
1020.9 (2679.2-1658.3) difference in -2logL between the null model and model with patient 
and centre variables, 89% (907) of the difference was observed when including the patient 
factors only (Appendix S5).   
 
Access to the Transplant Waiting List After Starting Dialysis 
Of 1970 participants included in this analysis, 585 (30%) were listed within 2 years of 
starting dialysis with a mean age of 49 years. The IQR across centres was 25%-40%. 
Associations between patient and centre variables and the likelihood of being listed after 
starting dialysis were characterized using univariable (Appendix S6 & S7) and multivariable 
(Appendix S8) Cox regression; before proceeding to analyse them in a final multivariable 
Cox proportional hazards regression model including imputed missing data (table 3). 
 
Several patient factors were independently associated with reduced access to listing after 
starting dialysis. These included: increasing age, female gender, having vascular disease, 
heart failure, type II diabetes, the presence of blood borne viruses, a previous history of 
malignancy, being a current smoker, and having a BMI >35.  
 
As with pre-emptive listing, lower socioeconomic status was associated with reduced access 
to listing after starting dialysis. Living in rented/housing association accommodation, lack of 
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car ownership, and being long term sick/disabled or being retired from paid work, as 
compared to being in full time/part time employment, were all negatively associated with 
being listed within 2 years of starting dialysis. In contrast, having a university degree, being 
on Peritoneal Dialysis as opposed to Haemodialysis, and Asian ethnicity were all associated 
with an higher likelihood of being listed.  
 
Amongst centre practice patterns, having >6 consultant nephrologists in the centre (OR 1.3 
CI: 1.00-1.59) was associated positively with being listed within 2 years of starting dialysis as 
was having a multidisciplinary team (MDT) approach to listing all patients for transplantation 
(OR 1.2 CI: 0.99-1.52). An MDT approach was defined as having a multi-disciplinary team of 
physicians, surgeons and other allied health care professionals who regularly convened to 
discuss patients under consideration for transplant listing before activation. 
 
Utilisation of a written protocol for listing patients for transplantation (OR 0.7 CI: 0.58-0.90) 
was negatively associated with being listed within 2 years of starting dialysis. Of the  
(7166.2-6566.8) 599.4 difference in -2logL between the null model and model with patient 
and centre variables, 97% (583.8) of the difference was observed when including the patient 
factors only (Appendix S9). After adjusting centre factors along with patient factors though 
much of the observed inter-centre variation from unadjusted analyses was again reduced 
there was still evidence of a difference between the centres (p=0.041, 1df).  
 
Interactions and Competing Risk Analysis 
When considering age as a linear factor, an interaction with type 2 diabetes was found to be 
important in the model (p=0.002, 1df). The association between increasing age and time to 
listing was stronger in participants with type 2 diabetes (data not shown). As for the 
competing risk analysis, sub-hazard ratios derived did not highlight any significant 
differences. 
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Discussion 
This national prospective cohort study of patients aged <75 years starting RRT in the UK 
found significant variation between kidney centres in access to pre-emptive listing for kidney 
transplantation and listing after starting dialysis. This was largely explained by patient case-
mix factors though some centre level effects were also found to be important. There was 
evidence of socioeconomic inequity in both measures of listing, despite extensive 
comorbidity adjustment; ethnic minority associations were inconsistent and inequity was only 
seen for pre-emptive listing. 
 
Strengths and Limitations 
The main strengths of this study are its prospective cohort design, national 
representativeness and high levels of data completeness (especially for socioeconomic 
status and co-morbidity) which meant that it was not subject to the inherent weaknesses of 
retrospective studies that have affected studies exploring access to transplantation to date. 
As for limitations, this study was observational so causal relationships cannot be 
determined. There was also no adjustment for comorbidity severity, or for pre transplant 
work-up. In the case of access to pre-emptive listing, analyses could not take into account all 
those patients who had CKD 5 or who were approaching the need for dialysis and were 
being worked up for listing, as these patients were not recruited as part of ATTOM. There 
may also be residual confounding factors not accounted for, as suggested by the 
persistence of a centre effect in the final models. 
 
Comparison with Other Studies and Implications on Health Policy 
Lower socioeconomic status was independently associated with both lower pre-emptive 
transplant listing and a lower likelihood of being listed after starting dialysis, even after 
extensive adjustment for demographic factors and comorbidity. Though this observation 
could arise in part from residual confounding by comorbidity due to lack of data on disease 
severity, this inequity is consistent with multiple studies in the US and the UK which have 
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highlighted reduced access to the transplant waiting list in socially deprived patients14,20. 
Similarly, several studies around the world have also shown that socioeconomically deprived 
individuals are less likely to undergo pre-emptive transplantation21,22, though this has never 
been reported in the UK to date. As for potential explanations, studies, primarily in the US, 
have suggested that socially deprived patients may not appreciate the advantages of kidney 
transplantation and may be less likely to complete the pre-transplant work up20. Additionally, 
clinicians may consciously or subconsciously manage patients in ways that make it less 
likely for socially deprived patients to be listed for transplantation23. Another possible reason 
may be lower levels of health literacy amongst patients of lower socioeconomic status. This 
hypothesis is supported by studies from the US and UK24,25 and may represent an area for 
targeted interventions to reduce inequity caused by social deprivation.  
 
As for the association of ethnicity and the transplant pathway, this was seen to vary by 
measure; both Asian and Black participants being less likely to be pre-emptively listed as 
compared to white participants; but Asian ethnicity was associated with an higher likelihood 
of being listed after starting dialysis. Other studies have also found conflicting associations in 
terms of ethnicity. Many studies in the US16,17,20,23 and UK14,15  have reported that ethnic 
minorities have decreased access to the transplant waiting list, whilst other studies have 
reported equal access26. One explanation for differing historical outcomes may be that 
previous studies reporting that ethnic minorities having reduced access to listing may have 
been confounded, by combining and analysing pre-emptive listing and listing after starting 
dialysis together; whilst in the present study they were treated independently. It is also 
possible that the lower likelihood of pre-emptive listing in ethnic minorities is partly a 
reflection of their lower rates of live donor transplantation, found in both the US and in the 
UK27. Institutional prejudice, distrust and reluctance to engage with the medical system, 
cultural and religious beliefs, and lack of suitable donors or concern over a higher risk for 
living donors from minority ethnic backgrounds have all been cited as possible reasons for 
these disparities28-31.  Further research is clearly needed to understand potential reasons.  
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In contrast the reasons for the observation that Asian participants had an higher likelihood of 
being listed once starting dialysis are unclear. Likewise, the reasons for the observation that 
female gender was negatively associated with listing after starting dialysis but not pre-
emptive listing is uncertain; it is revealed by analyzing these cohorts separately rather than 
combining them as in studies to date, and may be due to chance.  
 
Whilst patient case-mix was seen to account for the majority of inter-centre variation, some 
centre practice patterns were also seen to be associated with being listed. Being registered 
at a transplanting centre was associated with an increase in pre-emptive listing but not post-
dialysis listing.  This has been described in previous retrospective studies24-25, and may 
reflect more efficient listing processes in transplanting centres as a consequence of having 
access to on-site specialist clinicians to assist in assessing suitability; and to on-site live 
donor co-ordinators to aid earlier identification of potential living donors.  
 
The observation that a critical mass of consultant nephrologist availability (> 6 consultant 
nephrologists) was independently associated with a higher likelihood of listing also suggests 
a direct link between improved quality of patient care (i.e. early wait-listing) and senior 
workforce capacity. Whilst we are not able to clarify why this may be the case, a possible 
explanation is the ability to embed sub-specialist interest in transplantation and/or CKD 
pathway progress which may be more likely in larger units.   
 
The finding that discussing transplantation with all patients and not utilising a written protocol 
both improve listing is intriguing and has not been reported before. An inclusive approach to 
discussion about transplantation is likely to help eliminate personal bias and assist in a more 
patient-centred approach that may result in more open conversation, as well as aid in the 
early identification of potential live donors. Likewise, clinicians at centres not using a written 
protocol (i.e. centres which do not list patients using defined criteria as part of a in house 
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centre protocol), might benefit from listing more patients due to the ability to exercise more 
flexibility and their own personal clinical judgment which would otherwise be hampered by 
restrictions imposed by local guidelines. 
 
Conclusions 
This study has shown that patient case-mix and, to a lesser extent, centre practice patterns 
account for the majority of observed inter-centre variation in access to pre-emptive listing 
and listing after starting dialysis in the UK. However, socioeconomic inequity exists in access 
to kidney transplantation in the UK despite the existence of a universal healthcare system. 
Further research is needed to understand the causal pathways between socioeconomic 
status and listing for transplantation including the role of health literacy in influencing access 
to transplantation to reduce inequity.   
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Table 1: Baseline characteristics of participants in the Access to Transplantation and 
Transplant Outcome Measures study, United Kingdom, analysed for access to pre-emptive 
kidney transplant listing and kidney transplant listing within two years of starting dialysis  
Variable 
Access to Pre-emptive Listing    
Access to Listing within 2 years of 
Starting Dialysis 
Total N (%) 
Number Pre-
emptively listed 
N (%) 
  Total N (%) 
Number Listed 
within 2 years of 
starting Dialysis N, 
(%) 
Age (Mean, (SD)) 55 (13.6) 49 (12.9)  57 (13) 49 (14) 
Gender      
Male 1706 (64) 421 (60)  1285 (65) 406 (69) 
Female 970 (36) 285 (40)  685 (35) 179 (31) 
Ethnic Group      
White 2177 (81) 611 (87)  1566 (80) 416 (71) 
Asian 293 (11) 60 (8)  233 (12) 103 (18) 
Black  177 (7) 31 (4)  146 (7) 54 (9) 
Other 29 (1) 4 (1)  25 (1) 12 (2) 
Primary Renal Disease      
Diabetes 711 (28) 112 (16)  599 (30) 119 (20) 
Glomerulonephritis 428 (16) 148 (21)  280 (14) 142 (24) 
Hypertension 171 (6) 40 (6)  131 (7) 50 (9) 
Missing 30 (1) 10 (1)  20 (1) 14 (2) 
Other 388 (15) 88 (13)  300 (15) 75 (13) 
Polycystic 249 (9) 135 (19)  114 (6) 56 (10) 
Pyelonephritis 221 (8) 91 (13)  130 (7) 31 (5) 
Renal vascular disease 95 (4) 12 (2)  83 (4) 9 (2) 
Uncertain 383 (14) 70 (10)  313 (16) 89 (15) 
BMI      
Less than 20 165 (6) 40 (6)  125 (6) 41 (7) 
20 - <25 729 (27) 232 (33)  497 (25) 195 (33) 
25 - <30  771 (29) 274 (39)  497 (25) 186 (32) 
30 - <35  435 (16) 107 (15)  328 (17) 91 (16) 
35 - <40  202 (8) 24 (3)  178 (9) 34 (6) 
   131 (5) 6 (1)  125 (6) 8 (1) 
Missing 243 (9) 23 (3)  220 (11) 30 (5) 
Diabetes      
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No 1614 (60) 552 (78)  1065 (54) 398 (68) 
Type 1 256 (10) 80 (11)  176 (9) 60 (10) 
Type 2 776 (29) 67 (10)  709 (36) 115 (20) 
Missing 27 (1.0) 7 (1)  20 (1) 12 (2) 
Heart Disease      
No  2159 (81) 650 (92)  1509 (77) 508 (87) 
Yes 488 (18) 48 (7)  440 (22) 63 (11) 
Missing 29 (1) 8 (1)  21 (1) 14 (2) 
Heart Failure      
No 2467 (92) 691 (98)  1776 (90) 551 (94) 
Yes 178 (7) 7 (1)  171 (9) 18 (3) 
Missing 31 (1) 8 (1)  23 (1) 16 (3) 
Atrial Fibrillation      
No 2547 (95) 687 (97)  1860 (94) 559 (96) 
Yes 97 (4) 11 (2)  86 (4) 10 (2) 
Missing 32 (1) 8 (1)  24 (1) 16 (3) 
Cardiac Valve 
Replacement 
     
No 2612 (98) 689 (98)  1923 (98) 568 (97) 
Yes 31 (1) 7 (1)  24 (1) 1 (0.2) 
Missing 33 (1) 10 (1)  23 (1) 17 (3) 
Pacemaker      
No 2604 (97) 694 (98)  1910 (97) 567 (97) 
Yes 41 (2) 4 (0.6)  37 (2) 2 (0.3) 
Missing 31 (1) 8 (1)  23 (1) 16 (3) 
Cerebrovascular 
Disease 
     
No 2422 (91) 674 (96)  1748 (89) 541 (93) 
Yes 222 (8) 23 (3)  199 (10) 28 (5) 
Missing 32 (1) 9 (1)  23 (1) 16 (3) 
Vascular Disease      
No 2432 (91) 686 (97)  1746 (89) 545 (93) 
Yes 212 (8) 12 (2)  200 (10) 24 (4) 
Missing 32 (1) 8 (1)  24 (1) 16 (4) 
Abdominal Aortic 
Aneurysm 
     
No 2597 (97) 693 (98)  1904 (97) 569 (97) 
Yes 46 (2) 4 (0.6)  42 (2) 1 (0.2) 
Missing 33 (1) 9 (1)  24 (1) 15 (3) 
Respiratory Disease      
No 2335 (87) 643 (91)  1692 (86) 523 (89) 
Yes 310 (12) 55 (8)  255 (13) 47 (8) 
Missing 31 (1) 8 (1)  23 (1) 15 (3) 
Liver Disease      
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No 2582 (97) 691 (98)  1891 (96) 563 (96) 
Yes 64 (2) 7 (1)  57 (3) 7 (1) 
Missing 30 (1) 8 (1)  22 (1) 15 (3) 
Blood Borne Viruses      
No 2576 (96) 688 (98)  1888 (96) 562 (96) 
Yes 70 (3) 10 (1)  60 (3) 9 (2) 
Missing 30 (1) 8 (1)  22 (1) 14 (2) 
Malignancy      
No 2328 (87) 659 93)  1669 (85) 545 (93) 
Yes 321 (12) 39 (6)  282 (14) 25 (4) 
Missing 27 (1) 8 (1)  19 (1) 14 (2) 
Mental Illness      
No 2422 (91) 657 (93)  1765 (90) 532 (91) 
Yes 225 (8) 41 (6)  184 (9) 39 (7) 
Missing 29 (1) 8 (1)  21 (1) 14 (2) 
Dementia      
No 2637 (99) 697 (99)  1940 (99) 568 (97) 
Yes 8 (0.3) 1 (0.1)  7 (0.4) 1 (0.2) 
Missing 31 (1) 8 (1)  23 (1) 16 (3) 
Smoking      
No 1145 (43) 364 (52)  781 (40) 253 (43) 
Current 381 (14) 66 (9)  315 (16) 73 (13) 
Ex-smoker 763 (29) 185 (26)  578 (29) 158 (27) 
Don’t Know 370 (14) 85 (12)  285 (15) 93 (16) 
Missing 17 (0.6) 6 (1)  11 (0.6) 8 (1) 
Born in UK      
No 485 (18) 86 (12)  399 (20) 149 (26) 
Yes 2032 (76) 578 (82)  1454 (74) 404 (69) 
Missing 159 (6) 42 (6)  117 (6) 32 (6) 
English First Language      
No 325 (12) 58 (8)  267 (14) 110 (19) 
Yes 2192 (82) 606 (86)  1586 (81) 443 (76) 
Missing 159 (6) 42 (6)  117 (6) 32 (6) 
Read Help       
No 2058 (77) 597 (85)  1461 (74) 459 (78) 
Yes 457 (17) 66 (9)  391 (20) 94 (16) 
Missing 161 (6) 43 (6)  118 (6) 32 (6) 
Accommodation      
Owned by you (outright 
or with a mortgage) 
1436 (54) 468 (66)  968 (49) 281 (48) 
Part rent, part owned 
(shared ownership) 
55 (2) 11 (2)  44 (2) 17 (3) 
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Rented privately from 
Council/ Housing 
Association 
861 (32) 145 (21)  716 (36) 203 (35) 
Other 154 (6) 37 (5)  117 (6) 49 (8) 
Missing 170 (6) 45 (6)  125 (6) 35 (6) 
Employment      
Working PT/FT 627 (23) 316 (45)  311 (16) 185 (32) 
Long term sick/disabled 700 (26) 132 (19)  568 (29) 156 (27) 
Retired from paid work 889 (33) 124 (18)  765 (39) 114 (20) 
Unemployed 173 (7) 37 (5)  136 (7) 65 (11) 
Other 122 (5) 52 (7)  70 (4) 33 (6) 
Missing 165 (6) 45 (6)  120 (6) 32 (6) 
Education      
Degree, Higher or NVQ 
4-5 
446 (17) 160 (23)  286 (15) 137 (23) 
GCSE, A-level or NVQ 1-
3 
1051 (39) 346 (49)  705 (36) 241 (41) 
No Qualifications 1023 (38) 160 (23)  863 (44) 175 (30) 
Missing 156 (6) 40 (6)  116 (6) 32 (6) 
Car Ownership      
No 658 (25) 76 (11)  582 (30) 153 (26) 
Yes 1852 (69) 586 (83)  1266 (64) 399 (68) 
Missing 166 (6) 44 (6)  122 (6) 33 (6) 
Civil Status      
Single (never married) 480 (18) 136 (19)  344 (17) 136 (23) 
Married 1386 (52) 388 (55)  998 (50) 286 (49) 
Living with partner 173 (7) 64 (9)  109 (6) 43 (8) 
Divorced 238 (9) 49 (7)  189 (10) 49 (8) 
Separated (but still 
legally married) 
81 (3) 12 (2)  69 (4) 19 (3) 
Widowed 148 (6) 14 (2)  134 (7) 17 (3) 
Missing 170 (6) 43 (6)  127 (6) 35 (6) 
Children in Household      
None 1978 (74) 472 (67)  1506 (76) 387 (66) 
1 264 (10) 97 (14)  167 (9) 76 (13) 
2 or more 265 (10) 92 (13)  173 (9) 88 (15) 
Missing 169 (6) 45 (6)  124 (6) 34 (6) 
Adults in Household      
0-1 699 (26) 127 (18)  572 (29) 154 (26) 
2 1261 (47) 378 (54)  883 (45) 263 (45) 
3 or more 545 (20) 156 (22)  389 (20) 134 (23) 
Missing 171 (6) 45 (6)   126 (6) 34 (6) 
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Table 2 – Associations of patient-level and centre-level characteristics with listing for pre-
emptive kidney transplantation*. 
Variable N 
Adjusted Odds Ratio 
(95% Confidence 
Interval) 
p-value 
Patient Variables±    
Age   <0.0001 
18-29 149 1  
30-39  235 0.9 (0.51-1.57)  
40-49  455 0.79 (0.47-1.32)  
50-59  657 0.57 (0.34-0.97)  
60-64  372 0.47 (0.26-0.87)  
65-75 808 0.19 (0.1-0.37)  
Ethnic Group   <0.0001 
White 2177 1  
Asian 293 0.49 (0.33-0.72)  
Black 177 0.43 (0.26-0.71)  
Other 29 0.23 (0.07-0.8)  
BMI   <0.0001 
Less than 20 184 0.66 (0.4-1.09)  
20 - <25 798 1  
25 - <30  845 1.31 (0.99-1.73)  
30 - <35  482 0.97 (0.69-1.38)  
35 - <40  223 0.31 (0.18-0.54)  
   144 0.12 (0.05-0.28)  
Time Since First Seen 
by Nephrologist 
  <0.0001 
<1 Year 701 1  
1-3 Years 619 8.12 (5.44-12.1)  
>3 Years 1355 11.55 (8.05-16.55)  
Diabetes   <0.0001 
No 1626 1  
Type 1 266 1.12 (0.76-1.64)  
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Type 2 784 0.37 (0.26-0.52)  
Peripheral Vascular 
Disease   
   
No 2456 1  
Yes 220 0.29 (0.13-0.61) 0.0013 
Heart Disease     
No 2170 1  
Yes 506 0.55 (0.36-0.82) 0.004 
Heart Failure     
No 2490 1  
Yes 186 0.25 (0.08-0.77) 0.016 
Cerebrovascular 
Disease  
   
No 2448 1  
Yes 228 0.53 (0.3-0.92) 0.025 
Malignancy     
No 2340 1  
Yes 336 0.33 (0.2-0.53) <0.0001 
Smoking   0.0005 
No 1148 1  
Current 383 0.53 (0.36-0.78)  
Ex-smoker 769 0.95 (0.72-1.25)  
Don’t know 377 0.75 (0.52-1.07)  
Socioeconomic 
Variables    
Employment   <0.0001 
Working full time/ part 
time 
667 1  
Long term sick/disabled 746 0.42 (0.3-0.58)  
Retired from paid work 948 0.55 (0.37-0.82)  
Unemployed 185 0.51 (0.31-0.85)  
Other 130 0.93 (0.54-1.6)  
Accommodation   <0.0001 
Owned by you (Outright 
or with a Mortgage) 
1533 1  
Other  166 0.58 (0.34-1.0)  
Part rent, Part owned 
(shared ownership) 
59 0.32 (0.13-0.74)  
Rented Privately from 
Council / Housing 
Association  
918 0.55 (0.41-0.75)  
Car ownership    
No 701 1  
Yes 1975 1.98 (1.41-2.76) <0.0001 
Education     0.08 
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GCSE, A-level or NVQ 
1-3  
1115 1.26 (0.96-1.67)  
Degree, Higher or NVQ 
4-5  
477 1.06 (0.74-1.51)  
No Qualifications 1084 1  
Centre Level 
Variables  
   
Transplanting Centre    
No 48 1  
Yes 23 3.1 (2.36-4.07) <0.0001 
No. of Consultant 
Nephrologists 
   
  30 1  
>6 41 2.16 (1.5-3.1) <0.0001 
Transplantation 
Discussed with All 
Patients 
   
    
No 20 1  
Yes 51 1.39 (1.08-1.78) 0.0094 
* Derived using multivariable logistic regression and multiple imputation. 20 imputed data 
sets were modelled separately then combined to produce final parameter estimates. 
± Missing data was imputed for BMI (n=243), comorbidity (n= 30), time since first seen by a 
nephrologist (n=24) and socioeconomic variables (n=146). 
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Table 3 – Associations of patient-level and centre-level characteristics with listing for kidney 
transplantation within 2 years of starting dialysis* 
Variable N 
Adjusted Hazard 
Ratio (95% 
Confidence Interval) 
p-value 
Patient Variables    
Age   <0.0001 
18-29 86 1  
30-39  137 0.8 (0.56-1.12)  
40-49  280 0.64 (0.46-0.89)  
50-59  462 0.35 (0.25-0.49)  
60-64  290 0.27 (0.18-0.41)  
65-75 715 0.15 (0.1-0.23)  
Gender    
Male 1285 1  
Female 685 0.82 (0.68-0.99) 0.035 
Ethnic Group    0.002 
White 1566 1  
Asian 233 1.42 (1.12-1.79)  
Black 146 1.04 (0.76-1.43)  
Other 25 1.56 (0.85-2.87)  
BMI   <0.0001 
Less than 20 143 0.85 (0.6-1.21)  
20 - <25 561 1  
25 - <30  558 1.15 (0.93-1.42)  
30 - <35  369 0.88 (0.67-1.14)  
35 - <40  200 0.48 (0.33-0.7)  
   141 0.15 (0.08-0.3)  
Dialysis Modality    
Haemodialysis 1603 1  
Peritoneal dialysis 367 1.34 (1.1-1.64) 0.004 
Diabetes   <0.0001 
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No 1085 1  
Type 1 176 0.76 (0.57-1.02)  
Type 2 709 0.62 (0.49-0.79)  
Peripheral Vascular 
Disease  
   
No 1764 1  
Yes 206 0.6 (0.37-0.96) 0.035 
Heart Disease     
No 1520 1  
Yes 451 0.8 (0.59-1.09) 0.16 
Heart Failure     
No 1797 1  
Yes 173 0.58 (0.36-0.93) 0.025 
Blood Borne Viruses    
No 1906 1  
Yes 64 0.36 (0.18-0.71) 0.0035 
Malignancy     
No 1677 1  
Yes 293 0.33 (0.2-0.53) <0.0001 
Smoking   0.05 
No 784 1  
Current 316 0.76 (0.58-1.0)  
Ex-smoker 582 1.17 (0.95-1.45)  
Don’t know 289 1.06 (0.82-1.36)  
Socioeconomic 
Variables    
Employment   <0.0001 
Working full time/ part 
time 
331 1  
Long term sick/disabled 606 0.54 (0.43-0.68)  
Retired from paid work 814 0.58 (0.42-0.8)  
Unemployed 144 0.77 (0.56-1.06)  
Other 75 0.74 (0.5-1.1)  
Accommodation   0.009 
Owned by you (Outright 
or with a Mortgage) 
1035 1  
Other  126 0.81 (0.58-1.13)  
Part rent, Part owned 
(shared ownership) 
47 1.07 (0.64-1.8)  
Rented Privately from 
Council / Housing 
Association  
762 0.76 (0.61-0.94)  
Car ownership    
No 619 0.73 (0.6-0.9) 0.0026 
Yes 1351 1  
Education   0.01 
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GCSE, A-level or NVQ 
1-3  
749 1.05 (0.85-1.3)  
Degree, Higher or NVQ 
4-5  
305 1.38 (1.07-1.79)  
No Qualifications 916 1  
Centre Level Variables     
Consultant 
Nephrologists 
   
  30 1  
>6 41 1.26 (1.0-1.59) 0.054 
MDT    
No  17 1  
Yes 54 1.23 (0.99-1.52) 0.057 
Written Protocol for 
listing 
   
No 21 1  
Yes 50 0.72 (0.58-0.9) 0.0033 
 
* Derived using multivariable Cox regression and multiple imputation. 20 imputed data sets 
were modelled separately then combined to produce final parameter estimates. 
± Missing data was imputed for BMI (n=220), comorbidity (n=22) and socioeconomic 
variables (n=104). 
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Figure 1: Flow diagram showing the study recruitment of participants (with inclusion and 
exclusion criteria) for (1) access to pre-emptive listing and (2) listing after starting dialysis 
 
(Option A) 
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Figure 1: Flow diagram showing the study recruitment of participants (with inclusion and 
exclusion criteria) for (1) access to pre-emptive listing and (2) listing after starting dialysis 
(Option B) 
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Figure 2 (a)* – Unadjusted funnel plot showing variation in proportion listed for pre-emptive 
kidney transplant by centre according to number of participants evaluated. 
*Centres with less than 10 observations are not shown 
** Number of Patients, denotes the number of participants from a given centre that were 
analysed (from cohort of patients recruited at each centre for the ATTOM study) 
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Figure 2(b)* – Risk adjusted funnel plot showing variation in proportion listed for pre-
emptive kidney transplant by centre according to number of participants evaluated  
*Risk adjusted for all patient and centre factors, using the mean of each adjustment variable 
across the cohort, associated with pre-emptive listing as highlighted in table 2. Centres with 
less than 10 observations are not shown. 
** Number of Patients, denotes the number of participants from a given centre that were 
analysed (from cohort of patients recruited at each centre for the ATTOM study) 
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